Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 16.7 USD 0.12% Market Closed
Market Cap: 2.5B USD

Wall Street
Price Targets

ADPT Price Targets Summary
Adaptive Biotechnologies Corp

Wall Street analysts forecast ADPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADPT is 20.25 USD with a low forecast of 18.18 USD and a high forecast of 22.05 USD.

Lowest
Price Target
18.18 USD
9% Upside
Average
Price Target
20.25 USD
21% Upside
Highest
Price Target
22.05 USD
32% Upside
Adaptive Biotechnologies Corp Competitors:
Price Targets
237690
ST Pharm Co Ltd
11% Upside
HVO
hVIVO PLC
162% Upside
2269
WuXi Biologics (Cayman) Inc
24% Upside
TXG
10X Genomics Inc
6% Upside
MRVI
Maravai LifeSciences Holdings Inc
20% Upside
DIM
Sartorius Stedim Biotech SA
19% Upside
4880
CellSource Co Ltd
127% Upside
RPID
Rapid Micro Biosystems Inc
174% Upside

Revenue
Forecast

Revenue Estimate
Adaptive Biotechnologies Corp

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 4 years is 22%.

21%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADPT's stock price target?
Price Target
20.25 USD

According to Wall Street analysts, the average 1-year price target for ADPT is 20.25 USD with a low forecast of 18.18 USD and a high forecast of 22.05 USD.

What is Adaptive Biotechnologies Corp's Revenue forecast?
Projected CAGR
22%

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 4 years is 22%.

Back to Top